Abstract
Calcium plays a pivotal role in biological functions, and serum calcium levels have been associated with numerous disorders of bone and mineral metabolism, as well as cardiovascular mortality. This study reports results from a genome-wide association study (GWAS) of serum calcium, integrating data from four independent cohorts totaling 12,865 individuals of European and Indian Asian descent. The meta-analysis demonstrates that serum calcium is significantly associated with SNPs in or near the calcium-sensing receptor (CASR) gene on chromosome 3q13. The top hit, rs1801725 ($p = 6.3 \times 10^{-37}$), is a missense variant explaining 1.26% of the variance in serum calcium. This association was replicated in an independent Icelandic cohort ($p = 1.02 \times 10^{-4}$). These findings confirm that common CASR variants modulate serum calcium levels in the adult general population, highlighting the receptor's key role in calcium regulation.
Introduction
Serum calcium levels are tightly regulated within a narrow physiological range (2.15–2.55 mmol/L) due to their critical involvement in skeletal health, cardiac function, and neuromuscular signaling. While rare mutations in genes like CASR are known to cause severe familial calcium disorders, the genetic factors influencing normal variation in the general population have been less clearly defined. Previous studies were often limited by sample size or ethnic homogeneity. This research aims to identify common genetic variants (SNPs) regulating calcium levels across diverse populations and to evaluate their impact on clinical outcomes such as bone density and cardiovascular disease.
Methods
The study employed a Genome-Wide Meta-Analysis approach, combining data from four independent discovery cohorts.
- Association Mapping: Researchers scanned millions of Single Nucleotide Polymorphisms (SNPs) for correlation with serum calcium levels.
- Phenotype Correction: To account for the ~40% of calcium bound to albumin, "corrected calcium" formulas were used to estimate biologically active ionized calcium levels.
- Statistical Meta-Analysis: Results were combined using inverse variance weighting, with ethnicity-specific sub-analyses to manage population structure.
- Replication: Top findings were validated in an independent cohort of 4,126 individuals from Iceland.
Datasets
The discovery phase utilized data from 12,865 individuals across:
- CoLaus: 5,404 individuals (Switzerland).
- LOLIPOP: 5,548 individuals (UK; European and Indian Asian descent).
- InCHIANTI: 1,196 individuals (Italy).
- BLSA: 717 individuals (USA).
Validation: * deCODE: 4,126 individuals (Iceland).
Results and Key Insights
The analysis revealed that common variation in serum calcium is primarily driven by a single locus.
- The Centrality of CASR: Unlike many polygenic traits, serum calcium variation is dominated by the Calcium-Sensing Receptor (CASR) gene. No other genomic region reached genome-wide significance.
- Substantial Effect Size: The lead SNP, rs1801725, explains 1.26% of the total variance in serum calcium, which is exceptionally high for a single SNP in a GWAS context. Each "T" allele increases serum calcium by approximately 0.0187 mmol/L.
- Cross-Ethnic Consistency: The CASR locus was the primary driver in both European and Indian Asian populations. The top SNPs in each group (rs1801725 and rs17251221) are in high linkage disequilibrium, indicating a shared biological signal.
- Functional Mechanism: The lead variant is a missense mutation (Alanine to Serine) in the intracellular tail of the CASR protein, a region essential for signal transduction.
- Clinical Associations: Despite the strong genetic link to calcium levels, the study found no significant association between these variants and bone mineral density, heart disease, or kidney stones in the cohorts examined.
Discussion
This study establishes CASR as the major genetic determinant of serum calcium levels in healthy adults. However, the 1.26% variance explained by CASR is small compared to the 50–78% heritability estimated from twin studies, suggesting that many other variants with smaller effects remain unidentified. The lack of association with clinical outcomes may be due to compensatory homeostatic mechanisms or the need for even larger sample sizes to detect subtle impacts on disease risk.
Summary updated